Increased CD69 expression on peripheral blood eosinophils after specific inhalation challenge.

Area of Science:

• Immunology
• Allergy and Asthma Research

Background:

• CD69 is a marker of eosinophil activation following cytokine stimulation.
• Previous studies linked CD69 expression to allergic inflammation sites.
• This study investigates CD69 on peripheral eosinophils post-inhalation challenge.

Purpose of the Study:

• To evaluate CD69 expression on peripheral blood eosinophils after a specific inhalation challenge (SIC) in asthmatic patients.
• To determine if peripheral eosinophil activation is detectable following exposure to sensitizing agents.

Main Methods:

• Flow cytometry was used to measure CD69 expression.
• Nine asthmatic patients underwent a positive SIC with various allergens.
• Eleven asthmatic patients received a placebo challenge; samples were collected at baseline, 120, and 240 minutes post-challenge.

Main Results:

• Baseline CD69 expression was similar between SIC-positive and placebo groups.
• A significant increase in CD69 expression on peripheral eosinophils was observed 240 minutes after SIC in positive patients compared to placebo.
• The percentage of peripheral blood eosinophils decreased significantly 120 and 240 minutes post-challenge in positive SIC patients.

Conclusions:

• CD69 expression on peripheral blood eosinophils significantly rises in asthmatic patients after exposure to sensitizing agents.
• Bronchial stimulation effects are detectable on peripheral blood eosinophils.
• CD69 serves as a marker for eosinophil activation in response to specific allergens in asthma.